DIMENSIONAL FUND ADVISORS LP

Holdings History for Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH)

Symbol: TBPH on Nasdaq
Investment type: Equity / Ordinary Share $0.00001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$16,071,946	858,957	+92,253	+12%	$18.71	Q4 2025
30 Sep 2025	0%	+0%	$11,193,148	766,704	+44,634	+6.2%	$14.60	Q3 2025
30 Jun 2025	0%	+0%	$7,965,250	722,070	+78,232	+12%	$11.03	Q2 2025
31 Mar 2025	0%	+0%	$5,750,764	643,838	+90,125		$8.93	Q1 2025
31 Dec 2024	0%	+0%	$5,210,598	553,713	+95,304	+21%	$9.41	Q4 2024
30 Sep 2024	0%	+0%	$3,694,882	458,409	+128,228	+39%	$8.06	Q3 2024
30 Jun 2024	0%	+0%	$2,799,541	330,181	+91,679	+38%	$8.48	Q2 2024
31 Mar 2024	0%	+0%	$2,139,363	238,502	+105,318	+79%	$8.97	Q1 2024
31 Dec 2023	0%	+0%	$1,497,171	133,184	+61,564	+86%	$11.24	Q4 2023
30 Sep 2023	0%	0%	$617,425	71,620	+16	+0.02%	$8.62	Q3 2023
30 Jun 2023	0%	+0%	$740,970	71,604	+71,604	NEW	$10.35	Q2 2023
31 Dec 2016		-0%	$0	0	-43,018	-100%	$19.99	Q4 2016
30 Sep 2016	0%	0%	$1,558,000	43,018	0		$36.22	Q3 2016
30 Jun 2016	0%	-0%	$976,000	43,018	-474	-1.1%	$22.69	Q2 2016
31 Mar 2016	0%	0%	$817,000	43,492	-30	-0.07%	$18.79	Q1 2016
31 Dec 2015	0%	+0%	$713,000	43,522	+20,004	+85%	$16.38	Q4 2015
30 Sep 2015	0%	-0%	$258,000	23,518	-1,088	-4.4%	$10.97	Q3 2015
30 Jun 2015	0%	-0%	$320,000	24,606	-4,472	-15%	$13.00	Q2 2015
31 Mar 2015	0%	0%	$505,000	29,078	-27	-0.09%	$17.37	Q1 2015
31 Dec 2014	0%	0%	$434,000	29,105	-15	-0.05%	$14.91	Q4 2014
30 Sep 2014	0%	0%	$671,000	29,120	0		$23.04	Q3 2014
30 Jun 2014	0%	+0%	$929,000	29,120	+29,120	NEW	$31.90	Q2 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.